Wolverine Trading, LLC Vir Biotechnology, Inc. Transaction History

Wolverine Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$21.19 - $40.01 $344,210 - $649,922	-16,244 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $228,434 - $398,525	7,376 Added 83.18%	16,244 $660,000
Q3 2021 Nov 12, 2021	BUY	$34.9 - $54.54 $107,980 - $168,746	3,094 Added 53.59%	8,868 $383,000
Q2 2021 Aug 06, 2021	BUY	$38.75 - $51.0 $223,742 - $294,474	5,774 New	5,774 $269,000

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.